Erratum To: Efficacy and Safety of Olmesartan Medoxomil 40 Mg/Hydrochlorothiazide 12.5 Mg Combination Therapy Versus Olmesartan Medoxomil 40 Mg Monotherapy in Patients With Moderate to Severe Hypertension
Clinical Drug Investigation - United Kingdom
doi 10.1007/s40261-012-0048-7
Full Text
Open PDFAbstract
Available in full text
Date
December 20, 2012
Authors
Publisher
Springer Science and Business Media LLC